Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000597642 | SCV000707862 | uncertain significance | not provided | 2017-04-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000619890 | SCV000735467 | likely benign | Cardiovascular phenotype | 2016-07-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001078576 | SCV001002711 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000597642 | SCV001817293 | likely benign | not provided | 2020-04-13 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000597642 | SCV001926977 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000597642 | SCV001975600 | likely benign | not provided | no assertion criteria provided | clinical testing |